[1]罗燕燕,季文莹,孙 倩,等.基于网络药理学的金匮肾气丸治疗阿尔茨海默病机制研究[J].医学信息,2024,37(06):22-27.[doi:10.3969/j.issn.1006-1959.2024.06.004]
　LUO Yan-yan,JI Wen-ying,SUN Qian,et al.Study on the Mechanism of Jinkui Shenqi Pill in the Treatment of Alzheimer’s Disease Based on Network Pharmacology[J].Journal of Medical Information,2024,37(06):22-27.[doi:10.3969/j.issn.1006-1959.2024.06.004]
点击复制

基于网络药理学的金匮肾气丸治疗阿尔茨海默病机制研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年06期
页码:
22-27
栏目:
中医药信息学
出版日期:
2024-03-15

文章信息/Info

Title:
Study on the Mechanism of Jinkui Shenqi Pill in the Treatment of Alzheimer’s Disease Based on Network Pharmacology
文章编号:
1006-1959（2024）06-0022-06
作者:
罗燕燕; 季文莹; 孙 倩; 等
（1.甘肃省中医院药学部，甘肃 兰州 730050；2.兰州大学第二医院药剂科，甘肃 兰州 730030；3.甘肃省中医院心功能检查科，甘肃 兰州 730050；4.甘肃省药品检验研究院，甘肃 兰州 730070）
Author(s):
LUO Yan-yan; JI Wen-ying; SUN Qian; et al.
(1.Pharmacy Department of Gansu Provincial Hospital of Traditional Chinese Medicine,Lanzhou 730050,Gansu,China; 2.Pharmacy Department of the Second Hospital of Lanzhou University,Lanzhou 730030,Gansu,China;3.Cardiac Function Examination Department of Gansu Provincial Hospital of Traditional Chinese Medicine,Lanzhou 730050,Gansu,China; 4.Gansu Provincial Institute of Drug Control,Lanzhou 730070,Gansu,China)
关键词:
金匮肾气丸; 阿尔茨海默病; 网络药理学
Keywords:
Jinkui Shenqi pill; Alzheimer’s disease; Network pharmacology
分类号:
R259
DOI:
10.3969/j.issn.1006-1959.2024.06.004
文献标志码:
A
摘要:
目的 采用网络药理学技术探究金匮肾气丸治疗阿尔茨海默病（AD）的潜在作用机制。方法 利用TCMSP数据库，以口服生物利用度OB≥30%和类药性指数DL≥0.18筛选金匮肾气丸治疗AD的相关活性化学成分，组方化学成分靶点，通过Genecards数据库获取与 AD 疾病相关的靶标，使用韦恩分析筛选化学成分靶点与疾病靶点二者治疗AD的潜在作用靶点；采用Cytoscape构建构建“活性成分-作用靶点”作用网络图，采用R软件中的“ClusterProfiler”软件包进行GO和KEGG通路富集分析。结果 共得到金匮肾气丸131个活性成分，216个化学成分靶点，如谷甾醇、玉兰脂素B、海风藤酮、汉辛酚、亚麻酸乙酯、泽泻醇B、黄连碱等；Genecards数据库获取到8718个AD相关蛋白基因；韦恩分析得到金匮肾气丸与AD的176个共同靶点，包括HSP90AA1、MAPK1、AKT1、JUN、RELA、FOS、ESR1、MAPK14、MYC等。GO分析显示共同靶点的生物功能主要涉及对氧化应激的反应、细胞对化学应激的反应、酰胺结合等过程；KEGG 富集主要涉及体剪切应力与动脉粥样硬化、糖尿病并发症中的AGE-RAGE信号通路等。结论 金匮肾气丸的主要活性成分为谷甾醇、玉兰脂素B、海风藤酮、汉辛酚、亚麻酸乙酯、泽泻醇B、黄连碱等，这些成分可通过HSP90AA1、MAPK1、AKT1、JUN、RELA、FOS、ESR1、MAPK14等关键靶点作用于体剪切应力与动脉粥样硬化、糖尿病并发症中的AGE-RAGE信号通路发挥治疗AD的作用。
Abstract:
Objective To explore the potential mechanism of Jingui Shenqi pills in the treatment of Alzheimer’s disease (AD) by network pharmacology.Methods The TCMSP database was used to screen the active chemical components of Jinkui Shenqi pills in the treatment of AD with oral bioavailability OB≥30% and drug-like index DL≥0.18, and the chemical component targets were composed. The targets related to AD disease were obtained by Genecards database, and the potential targets of chemical component targets and disease targets in the treatment of AD were screened by Wayne analysis. Cytoscape was used to construct the "active ingredient-target" action network diagram, and the "ClusterProfiler" software package in R software was used for GO and KEGG pathway enrichment analysis.Results A total of 131 active ingredients and 216 chemical targets of Jinkui Shenqi pills were obtained, such as sitosterol, magnolin B, kadsura ketone, octylphenol, ethyl linolenic acid, alisol B, coptisine, etc. 8718 AD-related protein genes were obtained from Genecards database. The 176 common targets of Jingui Shenqi pills and AD were obtained by Wayne analysis, including HSP90AA1, MAPK1, AKT1, JUN, RELA, FOS, ESR1, MAPK14, MYC, etc. GO analysis showed that the biological functions of the common targets were mainly involved in the response to oxidative stress, cell response to chemical stress, amide binding and other processes. KEGG enrichment mainly involved AGE-RAGE signaling pathway in body shear stress, atherosclerosis and diabetic complications.Conclusion The main active components of Jinkui Shenqi pill are sitosterol, magnolin B, kadsura ketone, wogonol, ethyl linolenic acid, alisol B, coptisine, etc. These components can play a role in the treatment of AD by HSP90AA1, MAPK1, AKT1, JUN, RELA, FOS, ESR1, MAPK14 and other key targets in the body shear stress and AGE-RAGE signaling pathway in atherosclerosis and diabetic complications.

参考文献/References:

[1]顾晓群.基于网络药理学探讨补肾益智方经PI3K/Akt/GSK3β信号通路干预轻度认知障碍小鼠的作用及机制[D].南京:南京中医药大学,2020.[2]曹甜甜,王亚飞,张文龙,等.经颅交流电刺激对阿尔兹海默病小鼠双侧海马有效连接的干预研究[J].西安交通大学学报,2023,57(4):80-87.[3]崔舒鹏,高敏.阿尔兹海默病患者血清MCP-1、ZO-1的表达与认知功能的相关性[J].海军医学杂志,2023,44(4):411-413.[4]罗连响,黄芳芳,吴锐剑,等.花青素对阿尔兹海默病关键药理途径的生物信息学分析及实验验证[J].中国免疫学杂志,2021,37(18):2217-2224.[5]刘雨欣,秦雪梅,高丽.脑细胞衰老在阿尔茨海默症发病机制中的潜在作用[J].药学学报,2022,57(7):1946-1953.[6]林凯莉,张世卿.去甲氧基姜黄素通过促进海马神经发生对阿尔兹海默症认知损伤的改善作用[J].中成药,2022,44(8):2476-2482.[7]李安祥,谢冉.解读金匮肾气丸及其成药的演变与应用[J].中医药通报,2020,19(2):18-20,23.[8]朱丽红,黄庆田.中成药金匮肾气丸组方认知状况的数据挖掘[J].江西中医药,2019,50(9):20-21.[9]张倩,杨旭,王媛,等.金匮肾气丸对去势大鼠骨微结构及ALP、OPG、IL-6的影响[J].中国骨质疏松杂志,2020,26(10):1475-1480.[10]Singh AK,Singh SK,Nandi MK,et al.Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer’s disease[J].Central Nervous System Agents in Medicinal Chemistry,2019,19:1. [11]夏金婵,从人愿,袁静,等.黄芩苷通过p38 MAPK/NLRP3通路对脂多糖诱导大鼠急性肺损伤的影响[J].中国实验方剂学杂志,2022,28(2):79-86.[12]赵帅,陈冬梅,虎娜,等.β-谷甾醇通过PI3K/AKT通路影响颗粒细胞增殖及凋亡[J].宁夏医科大学学报,2021,43(4):339-344.[13]严宁,杨春霞,马娟,等.β-谷甾醇对大鼠心肌缺血再灌注损伤和ERK1/2信号通路的影响[J].心血管病学进展,2020,41(3):321-325.[14]叶蓉,唐春凤,刘道光,等.金匮肾气丸与补中益气丸联用对自然衰老C57小鼠运动及代谢的影响[J].中国老年学杂志,2021,41(3):600-603．[15]刘冬梅,林钟鸿.金匮肾气丸对阴阳两虚型糖尿病肾病患者血糖水平及肾功能的改善效果[J].内蒙古中医药,2022,41(7):18-19.[16]冯楚辉.加味金匮肾气丸联合温针灸治疗脾肾阳虚型早泄的临床研究[D].广州:广州中医药大学,2021.[17]程艳,李扬,郭建伟,等.SOD融合蛋白降低阿尔兹海默症小鼠脑内氧化水平及改善认知功能[J].现代生物医学进展,2022,22(19):3634-3639,3679.[18]王准,孙谕莹,黄汉昌.氧化应激与阿尔茨海默病的病理关系及干预措施[J].生命科学,2023,35(4):519-528.[19]邵思迈,史洺,余姊阳,等.阿尔茨海默病中的β淀粉样肽与氧化应激[J].中国比较医学杂志,2021,31(10):131-135.[20]赵丽萍,缪林清,蒋鹭莲,等.针刺改善阿尔茨海默病氧化应激机制的研究现状与思考[J].世界科学技术-中医药现代化,2020,22(8):2670-2678.

相似文献/References:

[1]刘 璐,秦新月.阿尔茨海默病患者血尿酸水平变化的研究[J].医学信息,2018,31(02):96.[doi:10.3969/j.issn.1006-1959.2018.02.033]
　LIU Lu,QIN Xin-yue.Study on the Changes of Serum Uric Acid in Alzheimer 's Disease Patients[J].Journal of Medical Information,2018,31(06):96.[doi:10.3969/j.issn.1006-1959.2018.02.033]
[2]赖 超,成官迅.rs-fMRI、DTI及1H-MRS在阿尔茨海默病中的应用进展[J].医学信息,2018,31(13):41.[doi:10.3969/j.issn.1006-1959.2018.13.013]
　LAI Chao,CHENG Guan-xun.Application of rs-fMRI、DTI and 1H-MRS in Alzheimer’s Disease[J].Journal of Medical Information,2018,31(06):41.[doi:10.3969/j.issn.1006-1959.2018.13.013]
[3]唐娟娟,高春岭,秦凤琴.蒙特利尔认知评估量表在成都市郫都区老年性痴呆筛查中的应用分析[J].医学信息,2018,31(19):12.[doi:10.3969/j.issn.1006-1959.2018.19.004]
　TANG Juan-juan,GAO Chun-ling,QIN Feng-qin.Application Analysis of Montreal Cognitive Assessment Scale in Screening for Alzheimer’s Disease in Pidu District,Chengdu[J].Journal of Medical Information,2018,31(06):12.[doi:10.3969/j.issn.1006-1959.2018.19.004]
[4]杨联勇,沈金娥.阿尔茨海默病新药的临床实验研究[J].医学信息,2020,33(02):50.[doi:10.3969/j.issn.1006-1959.2020.02.014]
　YANG Lian-yong,SHEN Jin-e.Clinical Experimental Study of New Drugs for Alzheimer’s Disease[J].Journal of Medical Information,2020,33(06):50.[doi:10.3969/j.issn.1006-1959.2020.02.014]
[5]康晨瑶,刘 洲,周海红.NLRP3炎症小体在AD发病机制中的作用[J].医学信息,2021,34(12):40.[doi:10.3969/j.issn.1006-1959.2021.12.011]
　KANG Chen-yao,LIU Zhou,ZHOU Hai-hong.The Role of NLRP3 Inflammasome in the Pathogenesis of AD[J].Journal of Medical Information,2021,34(06):40.[doi:10.3969/j.issn.1006-1959.2021.12.011]
[6]韦春英,莫颖敏.阿尔茨海默病早期诊断的脑脊液和血液生物标志物研究[J].医学信息,2021,34(14):25.[doi:10.3969/j.issn.1006-1959.2021.14.007]
　WEI Chun-ying,MO Ying-min.Study on Cerebrospinal Fluid and Blood Biomarkers for Early Diagnosis of Alzheimer’s Disease[J].Journal of Medical Information,2021,34(06):25.[doi:10.3969/j.issn.1006-1959.2021.14.007]
[7]张 瑞,延沁儒.丹酚酸B调节Bax/Bcl-2的表达对阿尔茨海默病小鼠认知功能的影响及机制[J].医学信息,2021,34(17):70.[doi:10.3969/j.issn.1006-1959.2021.17.018]
　ZHANG Rui,YAN Qin-ru.Effects of Salvianolic Acid B on the Cognitive Function of Alzheimer’s Disease Mice and its Mechanism Regulating the Expression of Bax/Bcl-2[J].Journal of Medical Information,2021,34(06):70.[doi:10.3969/j.issn.1006-1959.2021.17.018]
[8]张 辉,张 颖.多奈哌齐联合司来吉兰对阿尔茨海默病患者认知功能及不良反应的影响[J].医学信息,2022,35(13):110.[doi:10.3969/j.issn.1006-1959.2022.13.024]
　ZHANG Hui,ZHANG Ying.Effect of Donepezil Combined with Selegilan on Cognitive Function and Adverse Reactions in Patients with Alzheimer’s Disease[J].Journal of Medical Information,2022,35(06):110.[doi:10.3969/j.issn.1006-1959.2022.13.024]
[9]于京虎.复方脑肽节苷脂联合多奈哌齐对阿尔茨海默病患者认知功能及SOD水平的影响[J].医学信息,2023,36(03):148.[doi:10.3969/j.issn.1006-1959.2023.03.031]
　YU Jing-hu.Effect of Compound Porcine Cerebroside and Ganglioside Combined with Donepezil on Cognitive Function and SOD Level in Patients with Alzheimer’s Disease[J].Journal of Medical Information,2023,36(06):148.[doi:10.3969/j.issn.1006-1959.2023.03.031]
[10]徐 静.综合康复护理对阿尔兹海默病患者认知功能及生活能力的影响[J].医学信息,2023,36(04):150.[doi:10.3969/j.issn.1006-1959.2023.04.031]
　XU Jing.Effect of Comprehensive Rehabilitation Nursing on Cognitive Function and Living Ability of Patients with Alzheimer’s Disease[J].Journal of Medical Information,2023,36(06):150.[doi:10.3969/j.issn.1006-1959.2023.04.031]

更新日期/Last Update: 1900-01-01